Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: The study on cognition and prognosis in the elderly (SCOPE)
- 15 September 2004
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 44 (6), 1175-1180
- https://doi.org/10.1016/j.jacc.2004.06.034
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- The Study on Cognition and Prognosis in the Elderly (SCOPE)Journal of Hypertension, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet, 2002
- Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular HypertrophyJAMA, 2002
- Cardiovascular protection and blood pressure reduction: a meta-analysisThe Lancet, 2001
- Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US HypertensivesHypertension, 2001
- Stroke is More Common than Myocardial Infarction in Hypertension: Analysis based on 11 Major Randomized Intervention TrialsBlood Pressure, 2001
- Study on COgnition and Prognosis in the Elderly (SCOPE)Blood Pressure, 1999
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionThe Lancet, 1997
- Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic HypertensionJAMA, 1991